CTS562: Neurobiology Lab

The PAIDI CTS 562 group is conformed by two research teams with lines of investigation funded in competitive National and International calls led by Dr. Carmen Castro González and Mónica García Alloza. The research of this group is aimed at studying the molecular and cellular mechanisms underlying pathologies of the nervous system, including neurodegenerative diseases such as Alzheimer's disease, diabetes mellitus type II, or amyotrophic lateral sclerosis. In addition, the mechanisms that regulate neurogenesis and glyogenesis in brain injuries caused by traumatic or ischemic lesions are studied, as well as neurogenesis in other brain regions in which the loss of neurons during aging results incognitive decline. In addition to the basic studies, the group is also working on the search for therapeutic options for the treatment of the above-mentioned pathologies.

In relation to productivity indicators, the group that has been continuously funded in competitive public calls both at regional and national level and in calls H2020 (4-5 grants per year in the last 5 years) has an average of 7 indexed publications per year in the last 5 years, has submitted 8 patent applications and has significant funding from private entities through technology transfer contracts. In relation to international collaborations, the group maintains close collaborations with groups of prestigious universities at international level such as Harvard University in the USA, Oxford University and Edinburgh University in the UK and Tsukuba University in Japan among others.